Bird Rock Bio is a clinical stage biopharmaceutical company focused on developing innovative immuno-inflammatory regulators. Backed by leading biotechnology venture investors, our strategy leverages biologic targets with substantial human proof of mechanism for the development of novel, best-in-class therapeutic antibodies with significant clinical and commercial differentiation.
Our Noble Purpose
To advance the discovery and development of first-in-class, best-in-class antibody therapeutics to validated targets for unique and emerging markets with significant medical need.
Our Noble Purpose
To advance the discovery and development of first-in-class, best-in-class antibody therapeutics to validated targets for unique and emerging markets with significant medical need.